These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21681968)

  • 1. First BRET-based screening assay performed in budding yeast leads to the discovery of CDK5/p25 interaction inhibitors.
    Corbel C; Wang Q; Bousserouel H; Hamdi A; Zhang B; Lozach O; Ferandin Y; Tan VB; Guéritte F; Colas P; Couturier C; Bach S
    Biotechnol J; 2011 Jul; 6(7):860-70. PubMed ID: 21681968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in silico approach for the discovery of CDK5/p25 interaction inhibitors.
    Zhang B; Corbel C; Guéritte F; Couturier C; Bach S; Tan VB
    Biotechnol J; 2011 Jul; 6(7):871-81. PubMed ID: 21681969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen inhibits CDK5 kinase activity by interacting with p35/p25 and modulates the pattern of tau phosphorylation.
    Corbel C; Zhang B; Le Parc A; Baratte B; Colas P; Couturier C; Kosik KS; Landrieu I; Le Tilly V; Bach S
    Chem Biol; 2015 Apr; 22(4):472-482. PubMed ID: 25865311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the interaction of cyclin-dependent kinase 5 with activator p25 and with p25-derived inhibitor CIP.
    Cardone A; Albers RW; Sriram RD; Pant HC
    J Comput Biol; 2010 May; 17(5):707-21. PubMed ID: 20500023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of thienoquinolone derivatives as selective and ATP non-competitive CDK5/p25 inhibitors by structure-based virtual screening.
    Chatterjee A; Cutler SJ; Doerksen RJ; Khan IA; Williamson JS
    Bioorg Med Chem; 2014 Nov; 22(22):6409-21. PubMed ID: 25438765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MultiBacMam Bimolecular Fluorescence Complementation (BiFC) tool-kit identifies new small-molecule inhibitors of the CDK5-p25 protein-protein interaction (PPI).
    Bellón-Echeverría I; Carralot JP; Del Rosario AA; Kueng S; Mauser H; Schmid G; Thoma R; Berger I
    Sci Rep; 2018 Mar; 8(1):5083. PubMed ID: 29572554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35.
    Amin ND; Albers W; Pant HC
    J Neurosci Res; 2002 Feb; 67(3):354-62. PubMed ID: 11813240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CDK5/P25 formation/inhibition in neurodegeneration.
    Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
    Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.
    Binukumar BK; Shukla V; Amin ND; Bhaskar M; Skuntz S; Steiner J; Winkler D; Pelech SL; Pant HC
    J Alzheimers Dis; 2015; 48(4):1009-17. PubMed ID: 26444778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches to the discovery of cdk5 inhibitors.
    Glicksman MA; Cuny GD; Liu M; Dobson B; Auerbach K; Stein RL; Kosik KS
    Curr Alzheimer Res; 2007 Dec; 4(5):547-9. PubMed ID: 18220519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying novel substrates for mouse Cdk5 kinase using the yeast Saccharomyces cerevisiae.
    Horiuchi Y; Asada A; Hisanaga S; Toh-e A; Nishizawa M
    Genes Cells; 2006 Dec; 11(12):1393-404. PubMed ID: 17121546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity.
    Büchner A; Krumova P; Ganesan S; Bähr M; Eckermann K; Weishaupt JH
    Neuromolecular Med; 2015 Mar; 17(1):12-23. PubMed ID: 25391294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of Cdk5 activity after hypoxia/ischemia injury reduces infarct size and promotes functional recovery in neonatal rats.
    Tan X; Chen Y; Li J; Li X; Miao Z; Xin N; Zhu J; Ge W; Feng Y; Xu X
    Neuroscience; 2015 Apr; 290():552-60. PubMed ID: 25665755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.
    Kesavapany S; Zheng YL; Amin N; Pant HC
    Biotechnol J; 2007 Aug; 2(8):978-87. PubMed ID: 17526058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Explaining the inhibition of cyclin-dependent kinase 5 by peptides derived from p25 with molecular dynamics simulations and MM-PBSA.
    Tan VB; Zhang B; Lim KM; Tay TE
    J Mol Model; 2010 Jan; 16(1):1-8. PubMed ID: 19466465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase 5 regulates degranulation in human eosinophils.
    Odemuyiwa SO; Ilarraza R; Davoine F; Logan MR; Shayeganpour A; Wu Y; Majaesic C; Adamko DJ; Moqbel R; Lacy P
    Immunology; 2015 Apr; 144(4):641-8. PubMed ID: 25346443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25.
    Sato K; Minegishi S; Takano J; Plattner F; Saito T; Asada A; Kawahara H; Iwata N; Saido TC; Hisanaga S
    J Neurochem; 2011 May; 117(3):504-15. PubMed ID: 21338355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
    Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
    J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinase-5 and p35/p25 activators in schizophrenia and major depression prefrontal cortex: basal contents and effects of psychotropic medications.
    Ramos-Miguel A; Meana JJ; García-Sevilla JA
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):683-9. PubMed ID: 22964075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors.
    Malmström J; Viklund J; Slivo C; Costa A; Maudet M; Sandelin C; Hiller G; Olsson LL; Aagaard A; Geschwindner S; Xue Y; Vasänge M
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5919-23. PubMed ID: 22889803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.